<?xml version="1.0" encoding="UTF-8"?>
<p>Finally, the development of new acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitors represents a viable approach to alleviate Alzheimer’s disease [
 <xref rid="B31-molecules-26-03198" ref-type="bibr">31</xref>]. The inhibition of BuChE and AChE is of great interest for the study of the treatment and slowing down of Alzheimer’s disease [
 <xref rid="B12-molecules-26-03198" ref-type="bibr">12</xref>,
 <xref rid="B32-molecules-26-03198" ref-type="bibr">32</xref>] and other neurodegenerative diseases. The inhibitory activity of 
 <italic>Lepechinia paniculata</italic> EO for the two enzymes evaluated has not been previously described in the literature, so new studies are necessary to establish its potential pharmacological use.
</p>
